← Leaderboards
Nicholas Thomas Seyfried
Emory University
$21,258,516
Attributed
$51,124,741
Total exposure
16
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,124,741 · 16
By mechanism
R01$18,061,635 · 4
RF1$17,465,710 · 5
U01$13,793,067 · 2
P30$1,305,642 · 3
R21$422,544 · 1
F32$76,143 · 1
Top collaborators
- Joshua M Shulman19 shared
- Allan I Levey14 shared
- Christopher A. Gaiteri6 shared
- Jeremy H. Herskowitz6 shared
- Srikant Rangaraju6 shared
- Juan Botas5 shared
- Zhandong Liu5 shared
- Levi Benjamin Wood5 shared
Most similar at Emory University
Same institution · by research overlap
- Anita H Corbett$18,954,736
- Kenneth H Moberg$7,741,465
- Jennifer Rha$113,828
- Callie Preast Wigington$196,575
- Kevin J. Jamal Morris$129,372
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseProteinsProteomicsInnovationBrainAutopsyMass Spectrum AnalysisProteomePathologyLinkNerve DegenerationPathway InteractionsSamplingNeuronsBaseTau ProteinsGeneticAgingSystems BiologyResolutionMolecularCoupledIn Vivo
Grant awards (56)
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.$948,518
R01 · FY2025 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$800,351
R01 · FY2025 · AG
VCID CWOW: Identifying Novel Targets to Treat Cerebral Amyloid Angiopathy$5,949,022
RF1 · FY2024 · NS
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia$1,695,881
U01 · FY2024 · NS · contact PI
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.$986,184
R01 · FY2024 · AG
Emory Alzheimer's Disease Research Center$337,662
P30 · FY2024 · AG · contact PI
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia$1,606,305
U01 · FY2023 · NS · contact PI
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease$1,063,165
R01 · FY2023 · AG
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia$1,641,048
U01 · FY2022 · NS · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,561,246
U01 · FY2022 · AG
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease$1,074,815
R01 · FY2022 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,050,306
R01 · FY2022 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$391,250
U01 · FY2022 · AG
Emory Integrated Proteomics Core$61,561
P30 · FY2022 · CA · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,413,975
U01 · FY2021 · AG
Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimerâs disease$1,116,974
RF1 · FY2021 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,079,457
R01 · FY2021 · AG
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimerâs disease$1,039,370
R01 · FY2021 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$858,120
R01 · FY2021 · AG
Emory Integrated Proteomics Core$99,556
P30 · FY2021 · CA · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$13,600
U01 · FY2021 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,861,246
U01 · FY2020 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,019,854
R01 · FY2020 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$719,765
R01 · FY2020 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$641,161
R01 · FY2020 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$347,958
U01 · FY2020 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$271,410
U01 · FY2020 · AG
Emory Integrated Proteomics Core$99,556
P30 · FY2020 · CA · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$40,799
U01 · FY2020 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,456,658
U01 · FY2019 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,037,676
R01 · FY2019 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$733,953
R01 · FY2019 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$640,069
R01 · FY2019 · AG
Emory Integrated Proteomics Core$99,556
P30 · FY2019 · CA · contact PI
Glycoproteomics and the Glycosylation Code of the Brain in Asymptomatic and Symptomatic Alzheimerâs Disease$4,145,414
RF1 · FY2018 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,491,691
U01 · FY2018 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease$1,119,254
R01 · FY2018 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$665,200
R01 · FY2018 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$625,891
R01 · FY2018 · AG
A Novel RNA Binding Protein Modulates Tau Pathology$230,618
R21 · FY2018 · AG
ENNCF Proteomics Core$104,512
P30 · FY2018 · NS · contact PI
Emory Integrated Proteomics Core$99,556
P30 · FY2018 · CA · contact PI
Emory Integrated Proteomics Core$13,365
P30 · FY2018 · CA · contact PI
Emory Integrated Proteomics Core$4,861
P30 · FY2018 · CA · contact PI
Brain - Plasma Proteomics Biomarker Discovery and Validation in the US and UK$3,174,907
RF1 · FY2017 · AG
Building a high-resolution multi-omic AD interactome with the AMP-AD and M2OVE-AD Projects$3,079,393
RF1 · FY2017 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$679,825
R01 · FY2017 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$629,707
R01 · FY2017 · AG
A Novel RNA Binding Protein Modulates Tau Pathology$191,926
R21 · FY2017 · AG
ENNCF Proteomics Core$104,511
P30 · FY2017 · NS · contact PI
Emory Integrated Proteomics Core$71,924
P30 · FY2017 · CA · contact PI
Tau-Spliceosome Interactions in Alzheimer's Disease$648,994
R01 · FY2016 · AG
ENNCF Proteomics Core$104,511
P30 · FY2016 · NS · contact PI
ENNCF Proteomics Core$104,511
P30 · FY2015 · NS · contact PI
Characterizing TDP-43 isoforms in neurodegenerative disease$23,245
F32 · FY2010 · AG · contact PI
Characterizing TDP-43 isoforms in neurodegenerative disease$52,898
F32 · FY2009 · AG · contact PI